Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23797954 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed High Dose Ascorbic Acid Treatment of CMT1A
Condition: Charcot-Marie-Tooth Disease, Type Ia
Interventions: Drug: Ascorbic acid (Vitamin C);   Drug: placebo

Indicates status has not been verified in more than two years